Skip to main content
Log in

Multicentre comparison between slow-release furosemide and bendroflumethiazide in congestive heart failure

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The effects of slow-release furosemide and bendroflumethiazide in the ambulatory treatment of mild to moderate congestive heart failure were compared in a controlled multicentre study using a randomized, double-blind procedure. In the first trial, slow-release furosemide 60 mg daily was compared with 2.5 mg bendroflumethiazide; in the second trial the daily doses were 30 mg and 2.5 mg, respectively. There were 47 patients in Trial I and 39 in Trial II. The randomised allocation to the treatment regimen was made after a four-week period on bendroflumethiazide 2.5 mg daily, and treatment was continued for 12 weeks. Clinical and laboratory data were recorded before, during and at the end of the trial. Adverse effects were few and minor in both medication groups, and there were no significant intergroup differences. It was concluded slow-release furosemide 30 mg or 60 mg daily was as effective as bendroflumethiazide 2.5 mg daily for maintenance treatment in mild to moderate congestive heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hutcheon D, Nemeth E, Quinlan D (1980) The role of furosemide alone and in combination with digoxin in the relief of symptoms of congestive heart failure. J Clin Pharmacol 20: 59–68

    Google Scholar 

  2. The Criteria Committee of the New York Heart Association (1964) Diseases of the heart and blood vessels (nomenclature and criteria for diagnosis) 6th edn. Little, Brown, Boston

  3. Pothuizen LM, Chadha DR (1982) Treatment of congestive cardiac failure in elderly patients: randomized study of hydrochlorothiazide and slow-release furosemide. Curr Ther Res 32: 513–519

    Google Scholar 

  4. Vermeulen A, Chadha DR (1982) Slow-release furosemide and hydrochlorothiazide in congestive cardiac failure: a controlled trial. J Clin Pharmacol 22: 513–519

    Google Scholar 

  5. Finnerty FA, Maxwell MH, Lunn J, Moser M (1977) Long-term effects of furosemide and hydroclorothiazide in patients with essential hypertension. Angiology 28: 125–133

    Google Scholar 

  6. Araoye MA, Chang MY, Khatri IM, Freis ED (1978) Furosemide compared to hydrochlorothiazide. Long-term treatment in hypertension. Am Med Assoc 240: 1863–1866

    Google Scholar 

  7. Humphreys DM (1966) Acute gout apparently precipitated by furosemide. Br Med J 1: 1024–1025

    Google Scholar 

  8. Shapiro AP, Banedek TG, Small JL (1961) Effect of thiazide on carbohydrate metabolism in patients with hypertension. N Engl J Med 265: 1028–1033

    Google Scholar 

  9. Brown WJ, Brown FK (1967) Thiazide-induced alteration of carbohydrate tolerance in normal men. Curr Ther Res 9: 200–207

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pehrsson, S.K. Multicentre comparison between slow-release furosemide and bendroflumethiazide in congestive heart failure. Eur J Clin Pharmacol 28, 235–239 (1985). https://doi.org/10.1007/BF00543315

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00543315

Key words

Navigation